DocuSign stock rose 5% on analyst upgrade

4:53 PM 18 June 2021

DocuSign (DOCU.US) stock rose more than 5% despite the negative sentiment which prevails on the market today. Company shares are trading higher after Wedbush maintained an Outperform rating on the stock and raised its price target from $260 to $290. DocuSign continues to benefit from the strong demand for its platform as the concept of working from home gets more widely adopted across companies and countries. Therefore Wedbush analyst Daniel Ives  believes the company "is in a sweet spot to continue to receive significant customer spending given its unique solution set with an e-signature shift that has likely permanently changed among enterprises moving forward."

DocuSign (DOCU.US) stock launched today's session higher and is heading towards all-time high at  $285.16, however buyers struggle to break above upper limit of the broadening wedge formation. If sellers will manage to take advantage of this, then nearest support at $261.84 may be at risk. Source: xStation5

Share:
Back

Join over 1 600 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits